Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Transpl Immunol ; 40: 17-21, 2017 02.
Article in English | MEDLINE | ID: mdl-27979771

ABSTRACT

A 66-yo female patient (typed B*39:01, 44:02) underwent first left single lung transplant (typed B*81:01, 15:17) on 02/07/2016 with negative for DSA in current and historical samples. On 02/17/2016 strong de novo DSA (MFI=15,200, C1q+) to B81 were detected. The recipient has two children typed B*07:02, 44:02 B*27:03, 39:01, and had received multiple vaccinations. Twinrix, Zostavax and MMR vaccines contain viruses grown on live human lung fibroblasts (MRC-5, typed B*07:02, 44:02, and WI-38, typed B*08:01, 58:01). Each dose of vaccine used for injection is known to contain protein components of fibroblasts including HLA. Most likely rapid de novo DSA development is due to booster effect produced by five exposures to mismatched B locus alleles which share the following epitopes: 70IAQ, 65QIA, 65QIA+76esn, 69aa+80n, and 163ew+73te. The later three consist of paired non-self and self eplets. Although likelihood of bystander effect produced by multiple vaccinations is low its impact cannot be ruled out.


Subject(s)
Autoantigens/immunology , Epitopes, B-Lymphocyte/immunology , HLA-B Antigens/immunology , Immunity, Heterologous , Immunity, Humoral , Lung Transplantation , Vaccines/immunology , Aged , Cross Reactions , Female , Gravidity/immunology , Histocompatibility Testing , Humans , Immunization , Isoantigens/immunology , Pregnancy , Transplantation, Homologous , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL
...